Search

Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to change how multiple sclerosis is understood and treated.

We demonstrated that our assay could detect residual disease in AML patients after treatment with 92% sensitivity and 88% specificity—a significant leap forward compared to traditional monitoring

AseBio stands as the only sectoral organization represented in this body, alongside the digital sector, highlighting the recognition of biotechnology as a strategic sector within the field of emerging

Schrödinger will host a scientific workshop in Barcelona on July 8 to showcase how its molecular design platform leverages physics-based simulation and machine learning to accelerate drug discovery.

Bioga and five Galician biotech companies joined Swiss Biotech Day 2025, one of Europe’s leading life sciences events, to foster connections and explore partnerships with Swiss firms—highlighting

BCN HEALTH will participate in the Jornadas de la Asociación de Economía de la Salud (AES), which will take place in Madrid from June 18 to 20, with the presentation of two communications focused on

AseBio partners are leading the shift towards a more sustainable agri-food system, combining biotechnology, artificial intelligence, and regenerative practices to ensure safe and affordable food for

New patented product combines olive tree polyphenols and triterpenes to provide chronic inflammation control and improve gut function.

Navarre takes a strategic step toward the future with the launch of BioSintNA, an ambitious synthetic biology business plan promoted by Sodena and the Government of Navarre. The initiative aims to

ProtoQSAR continues to expand its role in the global scientific community through its active participation in SETAC Europe 2025, held in Vienna from May 11 to 15. As one of the leading events in

Biotech company MIMO Biosciences, a spin-off from the CIMA University of Navarra, has been honored with the prestigious 2025 EmprendeXXI Award. The prize is promoted by CaixaBank through DayOne and

The event featured the intervention of Josep Lluís Falcó, CEO of the company, who addressed the trends and challenges of the sector; Andreu M. Climent, CEO of CORIFY, as a success story of a start-up

Manos Seguras 3.0, designed in collaboration with a Granada-based startup and supported by ibs.GRANADA, boosts the prevention of healthcare-associated infections

ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck to assume clinical development and commercialization of ApTOLL.